What does Crystapharm do?
CRYSTAPHARM specializes in the development and manufacturing of pharmaceutical products, particularly focusing on innovative drug delivery systems. The company is dedicated to enhancing the effectiveness and safety of medications through advanced technology. With a commitment to quality and compliance, CRYSTAPHARM serves a diverse range of therapeutic areas.
- Sectors
- Accountants
- Signals
-
Poor liquidityPoor liquidity 0.13
The current ratio is below 1: may be insufficient to cover short-term debt.
ProfitableProfitable € 339KThe company reported a positive net result in the latest financial year.
Strong equityStrong equity € 1.28MStrong equity provides a buffer against setbacks.
Positive cashflowPositive cashflow € 635KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 339KPositive EBITDA: operating activities are profitable.
- Shareholders
- Wb Consult 25%, Odegas 25%, Clena Consulting 22,26%, +1 more
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2021
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
340K
|
€
249K
|
€
-34K
|
€
-9K
|
|
|
€
339K
|
€
247K
|
€
-39K
|
€
-10K
|
|
|
€
635K
|
€
213K
|
€
-81K
|
€
-55K
|
|
|
€
1.28M
|
€
1.28M
|
€
1.26M
|
€
1.34M
|
|
|
26.99%
|
30.33%
|
92.76%
|
71.21%
|
|
|
€
3.46M
|
€
2.93M
|
€
99K
|
€
543K
|
|
|
€
75K
|
€
22K
|
€
897K
|
€
581K
|
Publications 23
All publications- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Algemene Vergadering - Boekjaar 21/01/2026
- Ontslagen - Benoemingen 04/12/2024
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Wijziging Rechtsvorm - Maatschappelijke Zetel - Doel - Kapitaal - Aandelen - Ontslagen - Benoemingen - Algemene Vergadering - Boekjaar 03/10/2023
- Maatschappelijke Zetel 01/12/2022
- Maatschappelijke Zetel 10/11/2017
Frequently asked questions
Answers to the most common questions about Crystapharm, based on official government data and the filed annual accounts.
What is the VAT number of Crystapharm?
The VAT number of Crystapharm is BE0475.358.495.
When was Crystapharm established?
Crystapharm was founded in 20-07-2001.
What is the official address of Crystapharm?
The official address of Crystapharm is Noorderlaan 76 Waregem 8790.
What is the legal form of Crystapharm?
The juridical form of Crystapharm is Private limited company (BV/SRL).
What is the annual revenue of Crystapharm?
The 2025 accounts of Crystapharm do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Crystapharm do?
CRYSTAPHARM specializes in the development and manufacturing of pharmaceutical products, particularly focusing on innovative drug delivery systems. The company is dedicated to enhancing the effectiveness and safety of medications through advanced technology. With a commitment to quality and compliance, CRYSTAPHARM serves a diverse range of therapeutic areas.
Is Crystapharm a reliable company?
Crystapharm is a registered Rechtspersoon with company number 0475.358.495 and can be verified through the official CBE database.
What is the credit limit of Crystapharm?
The estimated credit limit of Crystapharm is €320,146.
Is Crystapharm still active?
Crystapharm currently has the status "Normal situation" and is active.